MedTrace Logo

Mapping Health-related Quality of Life in Pregnant Women With Thyroid Disease.

NCT04167423 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 253

Last updated 2022-05-12

No results posted yet for this study

Summary

Natural thyroid function changes during pregnancy. In up to tens of percent of pregnant women, these changes can lead to pathological fluctuations in hormone and antibody production. Although the effects on pregnancy and child development are well described, none has determined their influence on mother's emotional well-being and the quality of life.

At present, universal thyroid screening in pregnancy in the Czech Republic is not covered by health insurance. The aim of the project is to change this situation by providing quality of life estimate for the cost-effectiveness model.

This is a project of three specialized institutions aimed at mapping various aspects of the quality of life of pregnant women and describing the impact of thyroid disease on their lives. The project is a parallel study to a larger project Early screening for thyreopathy in pregnancy (CZ.03.2.63/0.0/0.0/15\_039/0009643) supported by the European Fund Operational Programme Employment through the National screening centre. The data will be collected through online questionnaire from women enrolled in the Early screening for thyreopathy in pregnancy (CZ.03.2.63/0.0/0.0/15\_039/0009643) who were screened for TSH, TPOAb and FT4.

Conditions

  • Thyroid Diseases
  • Pregnancy Related
  • Quality of Life

Sponsors & Collaborators

  • Charles University, Czech Republic

    collaborator OTHER

  • Institute of Health Information and Statistics of the Czech Republic

    collaborator OTHER_GOV

  • Value Outcomes Ltd.

    lead OTHER

Principal Investigators

  • Jan Tužil, MSc et Eng · Value Outcomes Ltd. et First Medical Faculty at Charles University, Prague

  • Tomáš Doležal, MD et PhD · Value Outcomes Ltd.

  • Jana Bartáková, Ing et PhD · Value Outcomes Ltd. et First Medical Faculty at Charles University, Prague

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-14
Primary Completion
2022-04-04
Completion
2022-04-04

Countries

  • Czechia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04167423 on ClinicalTrials.gov